Ledger.Open graph →
SEC Form D · filed November 19, 2018

NextCure, Inc

Offering
$93.4M
Sold
$93.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Beltsville, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Michael Yi · Beltsville, MDDirectorChau Q. Khuong · GERMANTOWN, MDDirectorSteven Cobourn · Beltsville, MDExecElaine N. Jones · Beltsville, MDDirectorStella Xu · Beltsville, MDDirectorMichael Richman · GERMANTOWN, MDExec · DirectorJudith Li · Danvers, MADirectorKevin N. Heller · Beltsville, MDExecDavid Kabakoff · La Jolla, CADirectorTim Q. Shannon · GERMANTOWN, MDDirectorStella Xu · Beltsville, MDDirectorMichael Richman · GERMANTOWN, MDExec · DirectorMichael Yi · San Diego, CADirectorJudith Li · Danvers, MADirectorChau Q. Khuong · GERMANTOWN, MDDirectorKevin N. Heller · Beltsville, MDExecDavid Kabakoff · San Diego, CADirectorSteven Cobourn · Beltsville, MDExecTim Q. Shannon · GERMANTOWN, MDDirectorElaine N. Jones · Beltsville, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗